NADiA ProsVue Prostate-specific Antigen Slope Is an Independent Prognostic Marker for Identifying Men at Reduced Risk of Clinical Recurrence of Prostate Cancer After Radical Prostatectomy-Reference-Cited by-同舟云学术

NADiA ProsVue Prostate-specific Antigen Slope Is an Independent Prognostic Marker for Identifying Men at Reduced Risk of Clinical Recurrence of Prostate Cancer After Radical Prostatectomy

Published:2012-12 Issue:6 Volume:80 Page:1319-1327
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Moul Judd W.,Lilja Hans,Semmes O. John,Lance Raymond S.,Vessella Robert L.,Fleisher Martin,Mazzola Clarisse,Sarno Mark J.,Stevens Barbara,Klem Robert E.,McDermed Jonathan E.,Triebell Melissa T.,Adams Thomas H.

Funder

National Institutes of Health

National Cancer Institute

Prostate Cancer Foundation

Sidney Kimmel Center for Prostate and Urologic Cancers

Publisher

Elsevier BV

Subject

Urology

Reference26 articles.

1. Cancer statistics, 2004;Jemal;CA Cancer J Clin,2004

2. Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate-specific antigen: an overview of the Department of Defense Center for Prostate Disease Research national database;Moul;Surgery,2002

3. Natural history of progression after PSA elevation following radical prostatectomy;Pound;JAMA,1999

4. Long-term survival after radical prostatectomy compared to other treatments in older men with local/regional prostate cancer;Liu;J Surg Oncol,2008

5. A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria;Gretzer;J Urol,2002

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study;Minerva Urologica e Nefrologica;2019-05

2. Evaluation of New Tests and Interventions for Prostate Cancer Management: A Systematic Review;Journal of the National Comprehensive Cancer Network;2018-11

3. Genome-Based Classification and Therapy of Prostate Cancer;Diagnostics;2018-09-02

4. What Can Be Expected from Prostate Cancer Biomarkers A Clinical Perspective;Urologia Internationalis;2017-09-15

5. Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?;Journal of Urology;2016-02